ID   EL-4/cCD20
AC   CVCL_E3E7
RX   PubMed=32651429;
CC   Genetic integration: Method=Transduction; Gene=VGNC; 52268; Dog MS4A1 (Note=With a C-terminal FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI:254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
RX   PubMed=32651429; DOI=10.1038/s41598-020-68470-9; PMCID=PMC7351721;
RA   Mizuno T., Kato Y., Kaneko M.K., Sakai Y., Shiga T., Kato M.,
RA   Tsukui T., Takemoto H., Tokimasa A., Baba K., Nemoto Y., Sakai O.,
RA   Igase M.;
RT   "Generation of a canine anti-canine CD20 antibody for canine lymphoma
RT   treatment.";
RL   Sci. Rep. 10:11476-11476(2020).
//